RV

Radhakrishnan Venu Murali

Active Director Director DIN 02285294
DIN 02285294 First appointment Sep 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Sep 2008
Shareholding value •••• Premium profile

About Radhakrishnan Venu Murali

Data last updated:

Radhakrishnan Venu Murali is a Director at Regenix Drugs Limited (since 2023) and Director at Visisht Health Care Centre Private Limited (since 2012). The companies operate in Healthcare and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹189 Cr; the largest is Regenix Drugs Limited at ₹188 Cr (FY 2024). Earlier, Radhakrishnan Venu Murali was a Director at Supradent Drugs Limited (2009–2015) and Managing Director at Regenix Dental Clinic Private Limited (from 2010) and 2 more.

DIN 02285294
Primary Designation Director
Industry Healthcare
First Appointment 10 Sep 2008
Oldest Company Age 21 yrs
Largest company Regenix Drugs Limited · ₹188 Cr (FY 2024)
Combined revenue ₹189 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regenix Drugs Limited U24232TN2007PLC063446
Director24 Sep 20232007₹188 Cr (FY 2024)Active
Director09 Aug 20122005₹54.1 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Supradent Drugs Limited U24230TZ2008PLC017228
Director01 Jun 20092008Active
Managing Director03 Dec 20102010Strike Off
Managing Director20 Oct 20092009Strike Off
Atm Healthcare Private Limited U85195TN2008PTC069234
Director10 Sep 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Regenix Dental Clinic Private Limited
Prudent Orthodontic Solutions Private Limited
Visisht Health Care Centre Private Limited
Atm Healthcare Private Limited
Premium access

Shareholding and investment profile for Radhakrishnan Venu Murali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radhakrishnan Venu Murali

Radhakrishnan Venu Murali currently holds 2 directorships: Regenix Drugs Limited (Director, since 24 Sep 2023, revenue ₹188 Cr (FY 2024)); Visisht Health Care Centre Private Limited (Director, since 09 Aug 2012, revenue ₹54.1 Lakh (FY 2024)).

Radhakrishnan Venu Murali was first appointed on 10 Sep 2008 as Director at Atm Healthcare Private Limited. The most recent appointment on record is 24 Sep 2023 at Regenix Drugs Limited.

The 2 current companies of Radhakrishnan Venu Murali that report revenue have a combined latest revenue of ₹189 Cr: Regenix Drugs Limited ₹188 Cr (FY 2024); Visisht Health Care Centre Private Limited ₹54.1 Lakh (FY 2024).

Radhakrishnan Venu Murali held 4 earlier board appointments: Supradent Drugs Limited (Director, 01 Jun 2009 to 03 Aug 2015); Regenix Dental Clinic Private Limited (Managing Director, from 03 Dec 2010); Prudent Orthodontic Solutions Private Limited (Managing Director, from 20 Oct 2009); Atm Healthcare Private Limited (Director, from 10 Sep 2008).

The current boards of Radhakrishnan Venu Murali's companies include Akshay Arvind (Regenix Drugs Limited), Ayyamperumal (Regenix Drugs Limited), Balaji Ramamurthy (Regenix Drugs Limited), Govindarajan Venkatakrishna (Regenix Drugs Limited), Guhan Ramamurthy (Regenix Drugs Limited), Gunasekaran Raju (Regenix Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available